Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sanofi SA (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SNY
Nasdaq
2834
https://www.sanofi.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sanofi SA (ADR)
Is Novavax Stock a Buy?
- May 18th, 2024 11:35 am
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
- May 17th, 2024 12:04 pm
Could Novavax Become the Next Moderna?
- May 17th, 2024 9:40 am
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
- May 16th, 2024 4:46 pm
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
- May 16th, 2024 2:51 pm
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
- May 16th, 2024 1:15 pm
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
- May 15th, 2024 10:32 am
Novavax Stock Just Tripled. Is It Too Late to Buy?
- May 15th, 2024 9:35 am
Sanofi to make €1bn biomanufacturing investment in France
- May 14th, 2024 11:01 am
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
- May 14th, 2024 9:11 am
Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
- May 14th, 2024 9:02 am
Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
- May 14th, 2024 7:01 am
Exploring Three Dividend Stocks On Euronext Paris
- May 14th, 2024 6:07 am
Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024
- May 13th, 2024 5:01 pm
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
- May 13th, 2024 4:51 pm
Meme Mania is Back: Buy these 3 Stocks
- May 13th, 2024 3:59 pm
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
- May 13th, 2024 3:02 pm
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
- May 13th, 2024 2:25 pm
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ...
- May 13th, 2024 12:32 pm
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
- May 13th, 2024 11:47 am
Scroll